Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs VAXART, INC. (VXRT)

LENZ Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. LENZ Therapeutics, Inc. and VAXART, INC. are of similar size ($94.6M and $92.4M). LENZ Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (16.0% vs −1,135.0%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 16 metrics below, VAXART, INC. leads on 13 and LENZ Therapeutics, Inc. on 3.

Valuation

Metric LENZ VXRT Biotechnology median
P/E n/m 2.85 10.60
P/S 8.82 0.50 9.40
P/B 0.57 1.36 2.13
Price to free cash flow n/m 2.81 25.18
EV/EBITDA 0.58 0.56 0.66
EV/Sales (6.96) 0.14 9.02
Earnings yield (129.27%) 35.14% (32.88%)
Free cash flow yield (117.13%) 35.55% (23.13%)

Profitability

Metric LENZ VXRT Biotechnology median
Gross margin 85.35% 100.00% 68.51%
Operating margin (1,211.17%) 16.63% 0.00%
Net margin (1,134.97%) 16.02% 0.00%
Free cash flow margin (1,033.28%) 17.64% 0.00%
Return on equity (72.69%) 62.42% (51.96%)
Return on assets (66.72%) 16.26% (46.06%)
Return on invested capital 0.00% 2,542.26% 0.00%

Growth

Metric LENZ VXRT Biotechnology median
Revenue growth (TTM) — 22.31% 6.76%
EPS growth (last fiscal year) (21.79%) 121.21% 29.88%
Revenue growth, 5-year CAGR — 125.76% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ VXRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.66 1.71 4.97
Net debt to EBITDA 3.22 (2.42) 1.01

Dividend

Metric LENZ VXRT Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LENZ VXRT Biotechnology median
Market cap 94.58m 92.41m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack